Isis Pharmaceuticals INC
SEC CIK 874015 · ISIS · last insider filing 2026-06-30
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Monia Brett P | Director · VP, Antisense Drug Discovery | filed 2012 - 2026 |
| Berthelsen Spencer R | Director | filed 2006 - 2026 |
| Hantson Ludwig | Director | filed 2026 - 2026 |
| Reikes Peter N | Director | filed 2018 - 2026 |
| Loscalzo Joseph | Director | filed 2014 - 2026 |
| Klein Joseph III | Director | filed 2006 - 2026 |
| Parshall B Lynne | Director · Executive Vice President | filed 2006 - 2026 |
| Diaz Allene M. | Director | filed 2021 - 2026 |
| Yang Michael J. | Director | filed 2023 - 2026 |
| Wender Joseph H | Director | filed 2006 - 2025 |
| Herman Joan E | Director | filed 2019 - 2025 |
| Hayden Michael R | Director | filed 2018 - 2025 |
| Muto Frederick T | Director | filed 2006 - 2022 |
| Crooke Stanley T | Director · Executive Chairman of Board | filed 2006 - 2021 |
| Castleman Breaux | Director | filed 2013 - 2020 |
| Reed John C | Director | filed 2006 - 2012 |
| Dimarchi Richard D | Director | filed 2006 - 2010 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| O'Neil Patrick R. | SVP, Legal and General Counsel | filed 2013 - 2026 |
| Baroldi Joseph | EVP, Chief Business Officer | filed 2022 - 2026 |
| Schneider Eugene | EVP, Chf Clinical Develop Offc | filed 2021 - 2026 |
| Swayze Eric | SVP, Research | filed 2020 - 2026 |
| Kordasiewicz Holly B. | EVP, Chief Development Officer | filed 2026 - 2026 |
| Jenne Kyle | EVP, Chf GL Pdt Str Ofcr | filed 2024 - 2026 |
| Birchler Brian | Vice President Level 14 | filed 2023 - 2026 |
| Devers Shannon L. | EVP, Chief Human Resourses Ofc | filed 2024 - 2026 |
| Hougen Elizabeth L | SVP, Finance and CFO | filed 2013 - 2026 |
| Bennett C Frank | Vice President | filed 2006 - 2026 |
| Geary Richard S | Sr VP, Development | filed 2008 - 2025 |
| Cadoret-Manier Onaiza | EVP,Chf GL Pdt Str & Oper Ofc | filed 2020 - 2024 |
| Mcdevitt Damien | Chief Business Officer | filed 2018 - 2019 |
| Boyce Sarah | Chief Business Officer | filed 2015 - 2018 |
| Ecker David J | Vice President | filed 2006 - 2008 |
| Treble Michael J | Vice President, Pres of Ibis | filed 2006 - 2008 |
| Jonas Jeffrey M | Executive Vice President | filed 2007 - 2008 |
| Xanthopoulos Kleanthis G | President of Regulus | filed 2007 - 2007 |
| Wedel Mark K | VP & Chief Medical Officer | filed 2006 - 2007 |
| Levin Arthur A | Vice President | filed 2006 - 2007 |
| Brown Richard K | Vice President | filed 2006 - 2006 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.